These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20095396)

  • 1. [Antiaggregant activity of hypoglycemic drugs].
    Spasov AA; Kucheriavenko AF; Maĭstrenko BP
    Eksp Klin Farmakol; 2009; 72(6):27-9. PubMed ID: 20095396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of hypoglycemic drugs on hemostasis].
    Spasov AA; Kucheriavenko AF; Salaznikova OA
    Eksp Klin Farmakol; 2010 Aug; 73(8):26-8. PubMed ID: 20919554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombotic activity of RU-891 antiaggregant agent].
    Spasov AA; Kucheriavenko AF; Tian' M; Anisimova VA
    Eksp Klin Farmakol; 2013; 76(6):25-6. PubMed ID: 24003486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
    Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
    Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of hypoglycemic drugs on hemorheological parameters].
    Spasov AA; Kucheriavenko AF; Salaznikova OA
    Eksp Klin Farmakol; 2009; 72(5):31-4. PubMed ID: 19928573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of acetylsalicylic acid on platelet aggregation and capillary bleeding in healthy cats].
    Hart S; Deniz A; Sommer B; Kietzmann M; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 Dec; 102(12):476-80. PubMed ID: 8591748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiaggregatory activity of hypoglycaemic sulphonylureas.
    Siluk D; Kaliszan R; Haber P; Petrusewicz J; Brzozowski Z; Sut G
    Diabetologia; 2002 Jul; 45(7):1034-7. PubMed ID: 12136403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
    Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
    Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro study of platelet antiaggregant activity of some 4-quinazolinone derivatives.
    Gravier D; Dupin JP; Casadebaig F; Hou G; Boisseau M; Bernard H
    Pharmazie; 1992 Feb; 47(2):91-4. PubMed ID: 1635928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thieno[2,3-d]pyrimidin-4(3H)-one derivatives and 1,2-dihydrogenated homologues: synthesis, enhanced in vitro antiaggregant activity for reduced compounds.
    Gravier D; Hou G; Casadebaig F; Dupin JP; Bernard H; Boisseau M
    Pharmazie; 1992 Oct; 47(10):754-7. PubMed ID: 1480651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes.
    de la Cruz JP; Pavia J; Bellido I; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):363-7. PubMed ID: 3412046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of chronic administration of epaden and acetylsalicylic acid on the antithrombotic potential of blood vessel walls in rabbits].
    Petrukhina GN; Remov MN; Makarov VA; Gandel' VG
    Eksp Klin Farmakol; 2002; 65(1):46-52. PubMed ID: 12025786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L; Vilageliu J; Freixes J
    Arzneimittelforschung; 1981; 31(10a):1790-5. PubMed ID: 6797443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antiaggregant activity of the synthetic antioxidant emoxipin].
    Stoliarov VA; Repin AN; Markov VA
    Eksp Klin Farmakol; 1993; 56(2):35-6. PubMed ID: 8348036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.